Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1306, 2001-01, pp. : 14-14
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Augmentation Therapy for 1 -Antitrypsin Deficiency
By Georges S. Juvelekian James K. Stoller
Drugs, Vol. 64, Iss. 16, 2004-01 ,pp. :
Access to resources
Recommend
Treatment of 1-antitrypsin deficiency is costly
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 309, 2001-01 ,pp. :
Treatment of 1-antitrypsin deficiency is costly
Inpharma, Vol. 1, Iss. 1284, 2001-01 ,pp. :
Flu vax not effective in α1-antitrypsin deficiency
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 547, 2008-01 ,pp. :
Emerging drugs for alpha-1-antitrypsin deficiency
Expert Opinion on Emerging Drugs, Vol. 15, Iss. 4, 2010-12 ,pp. :